Merck officer Williams proposes $3.19M share sale
The notice also lists a prior sale of 52,847 common shares on August 5, 2026, with an aggregate market value of $6,805,145.18.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Merck & Co., Inc. officer David Michael Williams reported an intended sale of 21,359 common shares, with an approximate sale date of November 2, 2026, and an aggregate market value of $3,185,464.17. The shares are listed as acquired from the issuer on November 2, 2026, through exercise of options under a registered plan, with cash payment. Williams also reported sales of 52,847 common shares on August 5, 2026, with an aggregate market value of $6,805,145.18.
Key Figures
Key Terms
Rule 144 regulatory
registered plan financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.